Indian Journal of Pharmacology

Pharmacology of GABA-Like compounds in relation to the brain dopaminergic system
IL Bonta
July-September 1973, 5(3):349-373

Gamma-amino-butyric-acid (GABA). Received little attention until 1950 when its occurrence as a normal constituent of the central nervous system in mammal organism was established. There is little doubt today that the aminoacids CABA and glycine have in mammals the function to inhibit some central neuronal processes, while to glutamate, excitatory functions have been ascribed. Many investigators call these substances as neuromodulators but others denote them as neurotransmitters (Cooper, Bloom and Roth, 1970). The evidence, however, that these amino acids are transmitters according to criteria as applied to monoamines like noradrenaline or dopamine, is still inconclusive. When administered to an intract organism these aminoacids do not reach the central nervous system and their pharmacological importance remained largely limited to changes in their level or function after treatment with other agents. Pharmacological interest in the GABA-system was increased however after the observation that gamma-hydroxy- butyrate (GHB) (Roth and Suhr, 1970) -which being a GABA-metabolite is a normal component of brain tissue-after systematic administration has marked neuro-depressive properties along with important effects on dopaminergic nerve terminals. Such effects are also described for gamma-butyro-lacton (GBL) (Roth and Suhr, 1970), 1, 4-butanediol (Gessa, Spano, Vagiu , Grabai. Tagliamonte arid Mameli, 1968), a n d more recently for 1-hydroxy-3 aminopyrrolidone-2 (HR-966) (Bonta, Devos, Grijsen, Hillern, Noach and Sim, 1971), which are also chemically related to GABA. This chemical relation together with the combined property of neurodepression and selective influence on brain dopamine avoke pharmacological interest for the following reasons: I. To study the correlation between "eurosedation (motor hypokinesia, sleep) and dopaminergic mechanisms; II. To investigate the possibility of a functional connection between the GABA-system and the dopaminergic system; III. To explore the clinical implications of this new class of compounds.

[ABSTRACT] Full text not available [PDF]

1,839

142

-

Preliminary observations on the anti-ovulatory activity present in Crotalaria juncea Linn seeds
S Bala, KN Garg
July-September 1973, 5(3):404-405

Full text not available [PDF]

1,255

108

-

Mechanism of secretion of N-Acetyl-4-amino-antipyrine in goat milk
NC Banerjee
July-September 1973, 5(3):394-396

Full text not available [PDF]

1,135

89

-

Experimental electrical convulsions and central catecholamines
SK Bapat, Bapat Veena, UR Bhardwaj
July-September 1973, 5(3):397-403

Full text not available [PDF]

1,050

69

-

Mechanism of hypothermic action of catecholamines in the cat
PN Saxena
July-September 1973, 5(3):374-377

Full text not available [PDF]

1,025

73

-

Quantitative evaluation of blood pressure responses in dogs to various vasoactive agents under the influence of commonly used anesthetics
SB Kolatkar, SD Kulkarni, GV Joglekar
July-September 1973, 5(3):378-383

Full text not available [PDF]

985

100

-

Effects of prostaglandins E1, E2, F1a and F2a on pulmonary circulation and other cardiocirculatory parameters
BR Madan, RS Gupta, V Madan, RK Soni
July-September 1973, 5(3):384-389

Full text not available [PDF]

989

94

-

Effects of prostaglandins E1, E2, F1alpha and F2alpha on ventricular arrhythmia in the Coronary ligated dogs
BR Madan, RK Soni, V Madan
July-September 1973, 5(3):390-393

Full text not available [PDF]

982

66

-